Federated Hermes Portfolio holdings
AUM
$53.1B
This Quarter Return
-0.77%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$31.1B
AUM Growth
+$31.1B
(-2.5%)
Cap. Flow
-$54.5M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
19.76%
Holding
2,147
New
188
Increased
725
Reduced
891
Closed
174
Top Buys
| 1 |
Procter & Gamble
PG
|
$305M |
| 2 |
Kinder Morgan
KMI
|
$160M |
| 3 |
Coca-Cola
KO
|
$143M |
| 4 |
Philip Morris
PM
|
$93.9M |
| 5 |
Alibaba
BABA
|
$93.7M |
Top Sells
| 1 |
LO
LORILLARD INC COM STK
LO
|
$447M |
| 2 |
AbbVie
ABBV
|
$211M |
| 3 |
ConocoPhillips
COP
|
$199M |
| 4 |
Thermo Fisher Scientific
TMO
|
$88M |
| 5 |
Expeditors International
EXPD
|
$76.2M |
Sector Composition
| 1 | Healthcare | 15.6% |
| 2 | Consumer Staples | 13.43% |
| 3 | Energy | 10.54% |
| 4 | Financials | 8.95% |
| 5 | Utilities | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dominion Energy
D
$50.3B
| $230M | 0.74% |
3,335,896
-190,236
| -5% | -$13.1M |
|
27
GSK
GSK
$79.3B
| $227M | 0.73% |
4,930,866
+695,431
| +16% | +$32M |
|
28
Wells Fargo
WFC
$262B
| $202M | 0.65% |
3,900,102
-948,184
| -20% | -$49.2M |
|
|
SLXP
29
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $189M | 0.61% |
1,206,557
-7,337
| -0.6% | -$1.15M |
|
|
RDS.B
30
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $188M | 0.6% |
2,373,329
-235,231
| -9% | -$18.6M |
|
31
Halliburton
HAL
$19.1B
| $186M | 0.6% |
2,883,727
+31,879
| +1% | +$2.06M |
|
32
BP
BP
$90.4B
| $184M | 0.59% |
4,188,697
-614,905
| -13% | -$27M |
|
33
JPMorgan Chase
JPM
$823B
| $182M | 0.58% |
3,016,321
+20,850
| +0.7% | +$1.26M |
|
34
Illumina
ILMN
$15.4B
| $181M | 0.58% |
1,104,046
-101,538
| -8% | -$16.6M |
|
35
DexCom
DXCM
$29.5B
| $178M | 0.57% |
4,446,933
-3,915
| -0.1% | -$157K |
|
36
American Electric Power
AEP
$58.6B
| $173M | 0.56% |
3,306,941
-107,838
| -3% | -$5.63M |
|
|
37
Kinder Morgan
KMI
$59.4B
| $167M | 0.54% |
4,353,092
+4,164,621
| +2,210% | +$160M |
|
38
Pfizer
PFE
$143B
| $166M | 0.53% |
5,602,842
+297,377
| +6% | +$8.79M |
|
39
PepsiCo
PEP
$206B
| $156M | 0.5% |
1,674,957
-70,980
| -4% | -$6.61M |
|
40
Biogen
BIIB
$21B
| $150M | 0.48% |
453,580
+33,801
| +8% | +$11.2M |
|
41
Gilead Sciences
GILD
$140B
| $148M | 0.48% |
1,390,007
-83,725
| -6% | -$8.91M |
|
42
Alkermes
ALKS
$5.09B
| $141M | 0.45% |
3,295,378
-203,898
| -6% | -$8.74M |
|
|
DYAX
43
DELISTED
DYAX CORPORATION
DYAX
| $137M | 0.44% |
13,584,600
| – | – |
|
|
CBST
44
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $136M | 0.44% |
2,051,064
-49,270
| -2% | -$3.27M |
|
45
Bristol-Myers Squibb
BMY
$98.3B
| $130M | 0.42% |
2,545,692
-117,108
| -4% | -$5.99M |
|
46
NXP Semiconductors
NXPI
$58.7B
| $130M | 0.42% |
1,903,400
-1,300
| -0.1% | -$89K |
|
|
SLCA
47
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $128M | 0.41% |
2,052,447
-338,289
| -14% | -$21.1M |
|
48
Martin Marietta Materials
MLM
$37.1B
| $123M | 0.4% |
951,860
+262,571
| +38% | +$33.9M |
|
49
Blackrock
BLK
$172B
| $118M | 0.38% |
358,244
+11,984
| +3% | +$3.93M |
|
50
CVS Health
CVS
$94B
| $117M | 0.38% |
1,475,792
-39,542
| -3% | -$3.15M |
|